Neuroimmune biology-An introduction

NeuroImmune Biology

Volumn 1, Issue C, 2001, Pages 3-45

  Berczi, Istvan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957071170     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(01)80005-3     Document Type: Editorial

References (360)

1. Sternberg E.M. The Balance Within: The Science Connecting Health and Emotions (2000), WH Freeman and Company, New York
2. Thompson W.G. Placebos: A review of the placebo response. Am J Gastroenterol 95 7 (2000) 1637-1643
3. Nowotny A. In: Nowotny (Ed). Beneficial effects of endotoxins (1993), Plenum Press, New York 1-55
4. Hammar J.A. The new views as to the morphology of the thymus gland and their bearing on the problem of the function of the thymus. Endocrinology 5 (1921) 543-573
5. Hammar J.A. The new views as to the morphology of the thymus gland and their bearing on the problem of the function of the thymus. Endocrinology 5 (1921) 731-760
6. Smith P.E. Effects of hypophysectomy upon the involution of the thymus in the rat. Anat. Rec 47 (1930) 119-129
7. Selye H. A syndrome produced by diverse nocuous agents. Nature (Lond) 138 (1936) 32
8. Selye H. Thymus and adrenals in the response of the organism to injuries and intoxication. Brit J Exp Path 17 (1936) 234-248
9. Selye H. Morphological changes in the fowl following chronic overdosage with various steroids. J Morph 73 (1943) 401-421
10. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinology 6 (1946) 117-230
11. Selye H. Effect of ACTH and cortisone upon an "anaphylactoid reaction". Can Med Assoc J 61 (1949) 553-556
12. Selye H. Stress and disease. Science 122 (1955) 625-631
13. Selye H. The Mast Cells (1965), Butterworth, Washington
14. Filipp G., Szentivanyi A., and Mess B. Anaphylaxis and nervous system. Acta Med Hung 2 (1952) 163-173
15. Szentivanyi A., and Filipp G. Anaphylaxis and the nervous system. Part II. Ann Allergy 16 (1958) 143-151
16. Filipp G., and Szentivanyi A. Anaphylaxis and the nervous system. Part III. Allergy 16 (1958) 306-311
17. Szentivanyi A., and Szekely J. Effect of injury to, and electrical stimulation of, hypothalamic areas on anaphylactic and histamine shock of the guinea pig. A preliminary report. Ann Allergy 14 (1956) 259-261
18. Townley R.G., Trapani I.L., and Szentivanyi A. Sensitization to anaphylaxis and to some of its pharmacological mediators by blockade of the beta adrenergic receptors. J Allergy 39 3 (1967) 177-179
19. Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42 (1968) 203-232
20. Szentivanyi A., Szentivanyi J., and Wagner H. Measurement of numbers of adrenoceptors in lymphocytes and lung tissue of patients with reversible obstructive airways disease. Clin Pharmacol Ther 27 (1980) 193-206
21. Szentivanyi A. The conformational flexibility of adrenoceptors and the constitutional basis of atopy. Triangle 18 4 (1979) 109-115
22. Szentivanyi A., Heim O., and Schultze P. Changes in adrenoceptor densities in membranes of lung tissue and lymphocytes from patients with atopic disease. Ann NY Acad Sci 332 (1979) 295-298
23. Szentivanyi A. La flexibilite de conformation des adrenocepteurs et la base constitutionelle du terrain allergique. Rev Franc Allergol 19 (1979) 205-214
24. Szentivanyi A., and Fitzpatrick D.F. The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides II. Effector reactivities in the efferent loop of the immune response. In: Filipp G. (Ed). Pathomechanismmus und Pathogenese Allergischer Reaktionen (1980), Werk-Verlag Dr. Edmund Banachewski, Grafelfing bei Munchen 511-580
25. Szentivanyi A., Polson J.B., and Krzanowski J.J. The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. I. Effector reactivities in the efferent loop of the immune response. In: Filipp G. (Ed). Pathomechanismus und Pathogenese Allergischer Reaktionen (1980), Werk-Verlag, Dr. Edmund Banachewski, Grafelfing bei Munchen 460-510
26. Szentivanyi A., Krzanowski J.J., Polson J.B., and Anderson W.H. Evolution of research strategy in the experimental analysis of the beta adrenergic approach to the constitutional basis of atopy. In: Oehling A., Mathov E., Glazer I., and Arbesman C. (Eds). Advances in Allergology and Clinical Immunology (1980), Pergamon Press, Oxford 301-308
27. Szentivanyi A. Effect of bacterial products and adrenergic blocking agents on allergic reactions. In: Samter M., Talmage D.W., Rose B., Sherman W.B., and Vaughan J.H. (Eds). Textbook of Immunological Diseases (1971), Little, Brown and Co., Boston, MA 356-374
28. Szentivanyi A., Krzanowski J.J., and Polson J.B. The autonomic nervous system: Structure, function, and altered effector responses. In: Middleton E., Reed C.E., and Ellis E.F. (Eds). Allergy: Principles and Practice (1978), The CV Mosby Co, St. Louis, MO 256-300
29. Szentivanyi A., and Williams J.F. The constitutional basis of atopic disease. In: Bierman C.W., and Pearlman D.S. (Eds). Allergic Diseases of Infancy, Childhood, and Adolescence (1980), WB Saunders Co, Philadelphia, PA 173-210
30. Szentivanyi A. Adrenergic and cholinergic receptor studies in human lung and lymphocytic membranes and their relation to bronchial hyperreactivity in asthma (1982), Patient Care Publications, Darien, CT 175-192
31. (abstract). Hackney J.F., and Szentivanyi A. The specificity of glucocorticoids in the relaxation of respiratory smooth muscle in vitro. J Allergy Clin Immunol 55 (1975) 123
32. (abstract). Hackney J.F., and Szentivanyi A. The unique action of glucocorticoid succinates on respiratory smooth muscle in vitro. The Pharmacologist 17 (1975) 271
33. Lowitt S., Szentivanyi A., and Williams J.F. Endotoxin inhibition of dexamethasone induction of tryptophan oxygenase in suspension culture of isolated rat parenchymal cells. II. Effect of in vivo pretreatment of rats with endotoxin. Biochem Pharmacol 31 (1982) 3403-3406
34. Szentivanyi A., and Szentivanyi J. Mechanisms of action of corticosteroids. Proceedings of the International Symposium on Allergy and Immunology. Lima, Peru (1985) 531-534
35. Korneva E.A., and Khai L.M. Effect of destruction of hypothalamic areas on immunogenesis. Fed Proc 23 (1964) T88
36. Jancso N. Role of the nerve terminals in the mechanism of inflammatory reactions. Bull. Millard Fillmore Hosp (Buffalo NY) (1960) 7-53
37. Jancso N. Desensitization with capsaicin and related acylamides as tool for studying the function of pain receptors. In: Lim R.K.S. (Ed). Pharmacology of Pain (1968), Pergamon Press, Oxford
38. Dougherty T.F. Effect of hormones on lymphatic tissue. Physiol Rev 32 (1952) 379-407
39. Nagy E., and Berczi I. Immunodeficiency in hypophysectomized rats. Acta Endocrinology 89 (1978) 530-537
40. Berczi I., Nagy E., Kovacs K., and Horvath E. Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinology 98 (1981) 506-513
41. Nagy E., Berczi I., and Friesen H.G. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinology 102 (1983) 351-357
42. Nagy E., Berczi I., Wren G.E., Asa S.L., and Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology 6 (1983) 231-243
43. In: Berczi I. (Ed). Pituitary Function and Immunity (with 12 contributing authors) (1986), CRC Press, Inc., Boca Raton, FL
44. Wannemacher Jr. R.W., Pekarek R.S., Thompson W.L., et al. A protein from polymorphonuclear leukocytes (LEM) which affects the rate of hepatic amino acid transport and synthesis of acute-phase globulins. Endocrinology 96 (1975) 651-661
45. Besedovsky H.O., del Rey A., and Sorkin E. Lymphokine-containing supernatants from Con A-stimulated cells increase corticosterone blood levels. J Immunol 126 (1981) 385-387
46. Berkenbosch F., van Oers J., del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-526
47. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
48. Nakamura H., Motoyoshi S., and Kadokawa T. Anti-inflammatory action of interleukin 1 through the pituitary-adrenal axis in rats. Eur J Pharmacol 141 (1988) 67-73
49. Uehara A., Gottschall P.E., Dahl R.R., and Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology 121 (1987) 1580-1582
50. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., and Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238 (1987) 519-521
51. McCann S.M., Karanth S., Kamat A., Les Dees W., Lyson K., Gimeno M., and Rettori V. Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation 1 (1994) 2-13
52. Russian. Pletsityi D.F., and Averi'anova L.L. The influence of vagotomy on the development of experimental endocarditis. Dokl Akad Nauk SSSR 167 1 (1966; Mar 1) 238-240
53. Williams J.M., Petersen R.G., Shea P.A., Schemdtje J.F., Bauer D.C., and Felten D.L. Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Res Bull 6 1 (1981; Jan) 83-94
54. Nance D.M. Innervation of the spleen in the rat: evidence for absence of afferent innervation. Burns J Brain Behav Immun 3 4 (1989; Dec) 281-290
55. Fleshner M., Goehler L.E., Hermann J., Relton J.K., Maier S.F., and Watkins L.R. Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull 37 6 (1995) 605-610
56. Metal'nikov S., and Chorine V. Roles des reflexes conditionels dans l'immunite. Ann Inst Pasteur 40 (1926) 893-900
57. Smith G.H., and Salinger R. Hypersensitivity and the conditioned reflex. Yale J Biol Med 5 (1933) 387-402
58. Ader R. Letter: Behaviorially conditioned immunosuppression. Psychosom Med 36 2 (1974) 183-184
59. MacQueen G., Marshall J., Perdue M., Siegel S., and Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 243 (1989) 83-85
60. Gorczynski R.M., Macrae S., and Kennedy M. Conditioned immune response associated with allogeneic skin grafts in mice. J Immunol 129 (1982) 704-709
61. Sci. Johnson H.M., Smith E.M., Torres B.A., and Blalock J.E. Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Nat Acad Sci USA 79 (1982) 4171-4174
62. Montgomery D.W., Zukoski C.F., Shah G.N., Buckley A.R., Pacholczyk T., and Russell D.H. Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun 145 2 (1987; Jun 15) 692-698
63. DiMattia, Gellersen B., Duckworth M.L., and Friesen H.G. Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem 265 27 (1990; Sept 25) 16412-16421
64. Salamonsen L.A., and Woolley D.E. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 44 1-2 (1999; Sept) 1-27
65. Kim H.G., Kassis J., Souto J.C., Turner T., and Wells A. EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol Histopathol 14 4 (1999; Oct) 1175-1182
66. Bodey B., Bodey Jr. B., Siegel S.E., and Kaiser H.E. Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microevironment. In Vivo 13 3 (1999; May-Jun) 267-294
67. Bianco P., Riminucci M., Kuznetsov S., and Robey P.G. Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology. Crit Rev Eukaryot Gene Expr 9 2 (1999) 159-173
68. Robinson G.W., Karpf A.B., and Kratochwill K. Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia 4 1 (1999; Jan) 9-19
69. Maeurer M.J., and Lotze M.T. Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity. Int Rev Immunol 16 3-4 (1998) 309-322
70. Fidler I.J. Angiogenesis and cancer metastasis. Cancer J Sci Am 6 Suppl 2 (2000 Apr) S134-S141
71. King A. Uterine leukocytes and decidualization. Hum Reprod Update 6 1 (2000; Jan-Feb) 28-36
72. Wagner J.G., and Roth R.A. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 52 3 (2000; Sept) 349-374
73. Pirtskhalaishvili G., and Nelson J.B. Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 44 1 (2000; Jun 15) 77-87
74. Tanaka Y. Integrin activation by chemokines: relevance to inflammatory adhesion cascade during T cell migration. Histol Histopathol 15 4 (2000; Oct) 1169-1176
75. Alford D., and Taylor-Papadimitriou J. Cell adhesion molecules in the normal and cancerous mammary gland. J. Mammary Gland Biol Neoplasia 1 2 (1996; Apr) 207-218
76. Kimber S.J., and Spanswick C. Blastocyst implantation: the adhesion cascade. Semin Cell Dev Biol 11 2 (2000; Apr) 77-92
77. Shiosaka S., and Yoshida S. Synaptic microenvironments-structural plasticity, adhesion molecules, proteases and their inhibitors. Neurosci Res 37 2 (2000; Jun) 85-89
78. Renard V., Cambiaggi A., Vely F., Blery M., Olcese L., Olivero S., Bouchet M., and Vivier E. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Transplant Rev 155 (1997) 205-221
79. Daëron M. Fc receptor biology. Annu. Rev. Immunol 15 (1997) 203-234
80. Isakov N. Immuoreceptor thyrosine-based activation motif (ITAM), a unique module lining antigen and Fc receptors to their signaling cascades. J Leukoc Biol 61 (1997) 6-16
81. Venters H.D., Tang Q., Liu Q., VanHoy R.W., Dantzer R., and Kelley K.W. A new mechanism of neurodegeneration: a proinflammatory cytokine, inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 96 17 (1999; Aug) 9879-9884
82. Yee D., and Lee A.V. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 5 1 (2000, Jan) 107-115
83. Kawashima K., and Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 86 1 (2000, Apr) 29-48
84. Ptasznik A., and Gewirtz A.M. Crosstalk between G protein-coupled receptors and tyrosine kinase signaling: Src take centre stages. Arch Immunol Ther Exp (Warsz) 48 1 (2000) 27-30
85. Bornfeldt K.E., and Krebs E.G. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 11 7 (1999; Jul) 465-477
86. Folli F., Saad M.J., Velloso L., Hansen H., Carandente O., Feener E.P., and Kahn C.R. Crosstalk between insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes 107 2 (1999) 133-139
87. th edition (1999), Lippincott-Raven 1-35
88. Clevenger C.V., Freier D.O., and Kline J.B. Prolactin receptor signal transduction in cells of the immune system. J Endocrinol 157 (1998) 187-197
89. Chang L., Crowston J.G., Cordeiro M.F., Akbar A.N., and Khaw P.T. The role of the immune system in conjuctival wound healing after glaucoma surgery. Surv Ophthalmol 45 1 (2000; Jul-Aug) 49-68
90. Schwartz M., and Cohen I.R. Autoimmunity can benefit self-maintenance. Immunol Today 21 (2000; Jun) 265-268
91. Neumann H. The immunological microenvironment in the CNS: implications on neuronal cell death and survival. J Neurol Transm Suppl 59 (2000) 59-68
92. Havran W.L. A role for epithelial gammadelta T cells in tissue repair. Immunol Res 21 2-3 (2000) 63-69
93. Abbott N.J. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol. Neurobiol 20 2 (2000; Apr) 131-147
94. (this volume). Antel J. Regulation of the Immune Response within the Central Nervous System. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Amsterdam 87-98
95. Stevens-Felten S.Y., and Bellinger D.L. Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 69 (1997) 99-131
96. (this volume). Nance D. Immunorgulation by the sympathetic nervous system. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Amsterdam 121-139
97. McKay D.M., and Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunology Today 15 (1994) 533-538
98. Derijk R.H., Strijbos P.J., van Rooijen N., Rothwell N.J., and Berkenbosch F. Fever and thermogenesis inresponse to bacterial endotoxin involve macrophage-dependent mechanisms in rats. Am J Physiol 265 5 Pt 2 (1993; Nov) 3-45
99. Berczi I., and Nagy E. Immune-endocrine interactions. In: Stefaneanu L., Sasano H., and Kovacs K. (Eds). Molecular and Cellular Endocrine Pathology (2000), Chapman and Hall 425-456
100. (this volume). Moldofsky H. Sleep, health and immunocompetence. In: Berczi I., and Gorczynski R.M. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Amsterdam 255-268
101. Müller E.E., Salerno F., Cocchi D., et al. Interaction between the thyrotropin releasing hormone-induced growth hormone rise and dopaminergic drugs: Studies in pathological conditions in theanimal and man. Clin Endocrinol 11 (1979) 645-656
102. Van den Berghe G., F d.Z., Valasselaers D., Schetz M., Verwaest C., Ferdinande P., and Lauwers P. Thyrotropin-releasing hormone in critical illness: From a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin,and growth hormone concentrations. Crit Care Med 24 (1996) 590-595
103. Li S., Crenshaw III E.B., Rawson E.J., Simmons D.M., Swanson L.W., and Rosenfeld M.G. Dawarf locus mutants lacking three pituitary cells types result from mutations in the POU-domain gene pit-1. Nature 347 (1990) 528-533
104. Castro P.R., Penalva R., Pereda M.P., Renner U., Reul J.M.H.M., Stalla G.K., Holsboer F., and Arzt E. Early activation of thyrotropin-releasing-hormone and prolactin plays a critical role during a T cell-dependent immune response. Endocrinology 140 (1999) 690-697
105. Raiden S., Polack E., Nahmod V., Labeur M., Holsboer F., and Larzt E. TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH. J Clin Immunol 15 (1995) 242-249
106. Wang J., and Klein J.R. Thymus-neuroendocrine interactions in extrathymic T cell development. Science 265 (1994) 1860-1862
107. Komorowski J., Zylinska K., Pawlikowski M., and Stepien H. Stimulatory effect of thyrotropin (TSH) on interleukin-2) (IL-2) release from human peripheral blood lymphocytes. A dose-reponse study in vitro. Hormones Metab Res 25 (1993) 598-599
108. Nicoll C.S. Prolactin and growth hormone: Specialists on one hand and mutual mimics on the other. Perspect Biol Med 25 (1982) 369-381
109. Berczi I. The immunology of prolactin. Semin Reprod Endocrinology 10 (1992) 196-219
110. Lewis U.J. Growth hormone-What is it and what does it do. Trends Endocrinol Metab 3 (1992) 117-121
111. Southard J.N., and Talamantes F. Placental prolactin-like proteins in rodents-Variations on a structural theme. Mol Cell Endocrinology 79 (1991) 3-45
112. Nickel B.E., Kardami E., and Cattini P.A. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells. Endocrinology 126 (1990) 971-976
113. Duckworth M.L., Robertson M.C., Schroedter I.C., Szpirer C., and Friesen H.G. Molecular genetics and biology of the rat placental prolactin family. In: Soares M.J., Handwerger S., and Talamantes F. (Eds). Trophoblast cells: pathways for maternal-embryonic communication (1993), Springer, New York 169-190
114. Berczi I., Chalmers I.M., Nagy N., and Warrington R.J. The immune effects of neuropeptides. Bailliere Clin Rheumatol 10 (1996) 227-257
115. Rohn W.M., and Weigent D.A. Cloning and nucleotide sequecing of rat lymphocyte growth hormone cDNA. Neuroimmunomodulation 2 (1995) 108-114
116. Palmetshofer A., Zechner D., Luger T.A., and Barta A. Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts. Mol Cell Endocrinology 113 (1995) 225-234
117. Sabharwal P., and Varma S. Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor. J Clin Endocrinol Metab 81 (1996) 2663-2669
118. L M. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 59 (1996) 599-614
119. Kelly P.A., Djiane J., Postel-Vinay M.C., and Edery M. The prolactin/growth hormone receptor family. Endocr Rev 12 (1991) 235-251
120. Wells J.A., and de Vos A.M. Structure and function of human growth hormone: Implications for the hematopoietins. Annu. Rev Biophys. Biomol Struct. 22 (1993) 329-351
121. Kishimoto T., Taga T., and Akira S. Cytokine signal transduction. Cell 76 (1994) 253-262
122. Ihle J.N. The Janus kinase family and signaling through members of the cytokine receptor superfamily. Proc Soc Exp Biol Med 206 (1994) 268-272
123. Rui H., Djeu J.Y., Evans G.A., Kelley P.A., and Farrar W.L. Prolactin receptor triggering: Evidence for rapid tyrosine kinase activation. J Biol Chem 267 (1992) 24076-24081
124. Clevenger C.V., Sillman A.L., and Prystowsky M.B. Interleukin-2 driven nuclear translocation of prolactin in cloned lymphocytes-T. Endocrinology 127 (1990) 3151-3159
125. Horseman N.D., and Yu-Lee L.Y. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocrines Rev 15 (1994) 627-649
126. Berczi I. Pituitary hormones and immune function. Acta Paediatr. (Suppl) 423 (1997) 70-75
127. Potter E.L., and Craig I.M. Pathology of the Fetus and the Infant. 3rd edition (1975), Year Book, Chicago
128. Arezzini C., De Gori V., Tarli P., and Neri P. Weight increase of body and lymphatic tissues in dwarf mice treted with human chorionic somatomammotropin (HCS). Proc Soc Exp Biol Med 141 (1972) 98-100
129. Berczi I., and Nagy E. Human placental lactogen is a hemopoietic hormone. Br J Haematol 79 (1991) 355-358
130. Berczi I., and Nagy E. The effect of prolactin and growth hormone on hemolymphopoietic tissue and immune function. In: Berczi I., and Kovascs K. (Eds). Hormones and Immunity (1987), MTP Press, Lancaster, England 145-171
131. Berczi I. The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation 1 (1994) 201-216
132. Bellone G., Geuna M., Carbone A., Silvestri S., Foa R., Emanuelli G., et al. Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells. J Cell Physiol 163 (1995) 221-231
133. Merchav S., Tatarsky I., and Hochberg Z. Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor-i. Br J Haematol 70 (1988) 267-271
134. Merchav S., Tatarsky I., and Hochberg Z. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J. Clin. Invest 81 (1988) 791-797
135. Kelley K.W., Arkins S., Minshall C., Liu Q., and Dantzer R. Growth hormone, growth factors and hematopoiesis. Hormone Res 45 (1996) 38-45
136. 3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA 83 (1986) 5663-5667
137. Berczi I., Nagy E., De Toledo S.M., Matusik R.J., and Friesen H.G. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 146 (1991) 2201-2206
138. Beschorner W.E., Divic J., Pulido H., Yao X., Kenworthy P., and Bruce G. Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor-I. Transplantation 52 (1991) 879-884
139. Binz K., Joller P., Foresch P., Binz H., Zapf J., and Foresch E.R. Repopulation of the atrophied thymus indiabetic rats by insulin-like growth factor I. Proc Natl Acad Sci USA 87 (1990) 3690-3694
140. Timsit J., Savino W., Safieh B., Chanson P., Gagnerault M.C., Bach J.F., and Dardenne M. Growth hormone and insulin-like growth factor-I stimulated hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 75 (1992) 183-188
141. Kaplan S.L., Grumbach M.M., Friesen H.G., and Costom B.H. Thyrotropin-releasing factor (TRF) effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopituitarydwarfism: further evidence for hypophysiotropic hormone deficiencies. J Clin Endocrinol Metab 35 (1972) 825-830
142. Spangelo B.L., Hall N.R.S., Ross P.C., and Goldstein A.L. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 14 (1987) 11-20
143. Nagy E., Berczi I., Wren G.E., Asa S.L., and Kovasc K. Immunomodulation by bromocriptine. Immunopharmacology 6 (1983) 231-243
144. Cesano A., Oberholtzer E., Contarini M., Geuna M., Bellone G., and Matera L. Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors. Immunopharmacology 28 (1994) 67-75
145. Bozzola M., Valtorta A., Moretta A., Cisternino M., Biscaldi I., and Schimpff R.M. In vitro and in vivo effect of growth hormone on cytotoxic activity. J Pediat 117 (1990) 596-599
146. Rovensky J., Ferencikova J., Vigas M., and Lukac P. Effect of growth hormone on the activity of some lysosomal enzymes in neutrophilic polymorphonuclear leukocytes of hypopituitary dwarfs. Int J Tissue React 7 (1985) 153-159
147. Wiedermann C.J., Niedermuhlbichler M., Beimpold, and Braunsteiner H. In vitro activation of neutrophils of the aged by recombinant human growth hormone. J Infect Dis 164 (1991) 1017-1020
148. Manfredi R., Tumietto F., Azzaroli L., Zucchini A., chiodo F., and Manfredi G. Growth hormone (GH)and the immune system: impaired phagocytic function in children with idiopathic GH deficienc is corrected by treatment with biosynthetic GH. J Pediat Endocrinol 7 (1994) 245-251
149. Cecilia-Fornari M., Fernanda-Palacios M., Diez R.A., and Intebi A.D. Decreased chemotaxis of neutrophils in acromegal and hyperprolatinemia. Eur J Endocrinology 130 (1994) 463-468
150. Rapaport R. Immunomodulation by growth hormone in humans. In: Berczi I., and Szelenyi J. (Eds). Advances in Psychoneuroimmunology (1994), Plenum Press, New York 83-98
151. Galdiero M., Donnarumma G., Cipollareo de l'Ero G., Marcatili A., Scarfogliero P., and Sommese L. Effect of growth hormone prolactin and insulin, on the release of IL-1 alpha, IFN-gamma and IL-4 by staphylococcal enterotoxin A-stimulatedsplenocytes. Eur Cytokine Netw 6 (1995) 187-194
152. LeRoith D., Yanowski J., Kaldjian E.P., Jaffe E.S., LeRoith T., Purdue K., Cooper B.D., Pyle R., and Adler W. The effects of growth hormone and insulin-like growth factor I onthe immune system of aged female monkeys. Endocrinology 137 (1996) 1071-1079
153. Gelato M.C. Aging and immune function: a possible role for growth hormone. Hormone Res 45 (1996) 46-49
154. Dorshkind K., and Horseman N.D. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormone in lymphocyte development and function. Insights fromgenetic models of hormone and hormone receptor deficiency. Endocrine Rev 21 (2000) 292-312
155. Bole-Feysot C., Goffin V., Edery M., Binart N., and Kelly P.A. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL-receptor knockout mice. Endocrine Rev 19 (1998) 225-268
156. Nagy E., and Berczi I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 146 (1991) 2776-2784
157. Komorowski J., Stepien H., and Pawlikowski M. The evidence of thyrolipberin/triiodothyronine control of TSH secretory response from human peripheral blood monocytes cultured in vitro. Neuropeptides 25 (1993) 31-34
158. Bagriacik E.U., and Klein J.R. The thyrotropin (thyroid-stimulating hormone) receptor is expressed on murine dendritic cells and on a subset of CD45Bhigh lymph node T cells: functional role for thyroid-stimulating hormone during immune activation. J Immunol 164 12 (2000; June 15) 6158-6165
159. Hsu J.-H., and Brent G.A. Thyroid hormone receptor gene knock outs. Trends Endocrinol Metab 9 (1998) 103-111
160. Fabris N., Mocchegiani E., and Provinciali M. Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine-immune interaction. Hormone Res 43 (1995) 29-38
161. Berczi I. The influence of pituitary-adrenal axis on the immune system. In: Berczi I. (Ed). Pituitary Function and Immunity (1986), CRC Press, Boca Raton, Florida 49-132
162. Besedovsky H.O., del Rey A., Klusman I., Furukawa H., Monge-Arditi G., and Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem. Mol Biol 40 (1991) 613-618
163. Vamvakopoulos N.C., and Chrousos G.P. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflamatory reaction. Endocrine Rev 15 (1994) 409-420
164. Heijnen C.J., Zijlstra J., Kavelaars A., Croiset G., and Ballieux R.E. Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes. Brain Behav Immun 1 (1987) 284-291
165. Catania A., Airaghi L., Colombo G., and Lipton J.M. Alpha-Melanocyte-stimulating Hormone. Normal Human Physiology and Disease States. Trends Endocrinol Metab 11 (2000; Oct) 304-308 8
166. Stein C., Schafer M., and Hassan A. Peripheral opioid receptor. Ann Med 27 (1995) 219-221
167. Taub D.D., Eisenstein T.K., Geller E.B., Adler M.W., and Rogers T.J. Immunomodulatory activity of μ- and k-selective opioid agonists. Proc Natl Acad Sci USA 88 (1991) 360-364
168. Alicea C., Belkowski S., Eisenstein T.K., Adler M.W., and Rogers T.J. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the k-opioid agonist U50, 488H. J Neuroimmunol 64 (1996) 83-90
169. Blalock J.E. Proopiomelanocortin and the immune-neuroendocrine connection. Ann N Y Acad Sci 885 (1999; Oct 20) 161-172
170. Catania A., and Lipton J.M. The neuropeptide alpha-melanocyte-stimulating hormone: a key component of neuroimmunomodulation. Neuroimmunomodulation 1 (1994) 93-99
171. Shimizu T., and Streilein J.W. Influence of alpha-melanocyte stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 8 (1994) 187-193
172. Grabbe S., Bhardwaj R.S., Mahnke K., Simon M.M., Schwarz T., and Luger T.A. Alphamelanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156 (1996) 473-478
173. King L.B., Vacchio M.S., Dixon K., Hunziker R., Margulies D.H., and Ashwell J.D. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3 (1995) 647-656
174. Wiegers G.J., Labeur M.S., Stec I., Klinkert W., Holsboer F., and Reul J.M.H.M. Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J Immunol 155 (1995) 1893-1902
175. Munck A., Naray-Fejes-Toth A., and Guyre P.M. Mechanisms of glucocorticoid actions on the immune system. In: Berczi I., and Kovacs K. (Eds). Hormones and Immunity (1987), MTP Press Ltd, Lancaster, England
176. Vacchio M.S., Papadopoulos V., and Ashwell J.D. Steroid production in the thymus: implications for thymocyte selection. J Exp Med 179 (1994) 1835-1846
177. Rook G.A. Glucocorticoids and immune function. Baillieres Best Pract Res Clin Endocrinol Metab 13 4 (1999; Dec) 567-581
178. Ashwell J.D., Lu F.W., and Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev Immunol 18 (2000) 309-345
179. Grasso G., Massai L., De Leo V., and Muscettola M. The effect of LHRH and TRH on human interferon-gamma production in vivo and in vitro. Life Sci 62 22 (1998) 2005-2014
180. Athreya B.H., Pletcher J., Zulian F., Weiner D.B., and Williams W.V. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. Clin Immunol Immuno Pathol 66 (1993) 201-211
181. Rouabhia M., Chakir J., and Deschaux P. Interaction between the immune and endocrine systems: Immunodulatory effects of luteinizing hormone. Prog Neuroendocrin Immunol 4 (1991) 86-91
182. Komorowski J., and Stepien H. FSH and LH induce interleukin-6 (IL-6) release from human peripheral blood monocytes cultures in vitro. A dose-response study. Hormone Metab Res 26 (1994) 438-439
183. Sullivan D.A. Endocrine regulation of the ocular secretory immune system. In: Berczi I., and Kovacs K. (Eds). Hormones and immunity (1987), MTP Press, Lancaster, England 54-92
184. Nelson J.L., and Steinberg A.D. Sex steroids, autoimmunity and autoimmune disease. In: Berczi I., and Kovacs K. (Eds). Hormones and Immunity (1987), MTP Press, Lancaster, England 93-119
185. Nagy E, Baral E, Berczi I. Immune System. In: Oettel M, editor-in-chief. Handbook ofExperimental Pharmacology. Estrogens and anti-estrogens. Section IV. Physiology and Pathophysiology of estrogens. Springer-Verlag (in press).
186. Lahita R.G. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 11 5 (1999; Sept) 352-356
187. + T-lymphocyte activity in vivo and in vitro in β2-microglobulin-deficient mice. Immunology 86 (1995) 162-167
188. Ahmed S.A., Talal N., and Christadoss P. Genetic regulation of testosterone-induced immune suppression. Cell Immunol 104 1 (1987) 91-98
189. Greenstein B.D., de Bridges E.F., and Fitzpatrick F. Aromatase inhibitors regenerate the thymus in aging male rats. Int J Immunopharm 14 (1992) 541-553
190. Araneo B.A., Dowell T., Diegel M., and Daynes R.A. Dihydrotesterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and γ-interferon, but not IL-2 by activated murine T. Blood 78 (1991) 688-699
191. Konstadoulakis M.M., Syrigos K.N., Baxevanis C.N., Syrigou E.I., Papamichail M., Peveretos P., Anapliotou M., and Golematis B.C. Effect of testosterone administration, pre- and postnatally, on the immune system of rats. Horm Metab Res 27 (1995) 275-278
192. Regelson W, Loria R, Kalimi M, Dehydroepiandrosterone (DHEA) - the "mother steroid". I. Immunologic action. Ann NY Acad Sci 719: 553-563.
193. Catania R.A., Angele M.K., Ayala A., Cioffi W.G., Bland K.I., and Chaudry I.H. Dehydroepiandrosterone restores immune function following trauma-haemorrhage by a direct effect on T lymphocytes. Cytokine 11 6 (1999; Jun) 443-450
194. Padgett D.A., and Loria R.M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J Immunol 153 (1994) 1544-1552
195. Suzuki T., Suzuki N., Daynes R.A., and Engleman E.G. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol ImmunoPathol 61 (1991) 202-211
196. Weksler M.E. Immune senescence and adrenal steroids: immune dysregulation and the action of dehydroepiandrosterone (DHEA) in old animals. Eur J Clin Pharmacol 45 (1993) S21-S23
197. Loria R.M., Padgett D.A., and Huynh P.N. Regulation of the immune response by dehydroepiandrosterone and its metabolites. J Endocrinol 150 (1996) S209-S220
198. Check J.H., Tarquini P., Gandy P., and Lauer C. A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatmentversus progesterone alone in primary habitual aborters. Gynecol Obstet Invest 39 (1995) 257-261
199. Fleming M.W., and Gamble H.R. Consequences of dose-dependent immunosuppression by progesterone on parasitic worm burdens in lambs. Am J Vet Res 54 (1993) 1299-1302
200. Parr M.B., Kepple L., McDermott M.R., Drew M.D., Bozzola J.J., and Parr E.L. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 70 (1994) 369-380
201. Kalo-Klein A., and Witkin S.S. Regulation of the immune response to Candida albicans by monocytes and progesterone. Am J Obstet Gynecol 164 (1991) 1351-1354
202. Nohmi T., Abe S., Dobashi K., Tansho S., and Yamaguchi H. Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal Candidiasis. Microbiol Immunol 39 (1995) 405-409
203. Li Z.G., Danis V.A., and Brooks P.M. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 11 (1993) 157-162
204. Szekeres-Bartho J., Barakonyi A., Polgar B., Par G., Faust Z., and Palkovics T. Szereday The role of gamma/delta T cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 42 1 (1999; Jul) 44-48
205. Manolagas S.C., Yu X.P., Girasole G., and Bellido T. Vitamin D and the hematolymphopoietic tissue: a 1994 update. Sem Nephrol 14 (1994) 129-143
206. Bouillon R., Garmyn M., Verstuyf A., Segaert S., Casteels K., and Mathieu C. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur J Endocrinology 133 (1995) 7-16
207. Yang S., Smith C., Prahl J.M., Luo X., and DeLuca H.F. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem. Biophys. 303 (1993) 98-106
208. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E., Allavena P., and Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164 9 (2000; May 1) 4443-4451
209. Daynes R.A., Enioutina E.Y., Butler S., Mu H.H., McGee Z.A., and Araneo B.A. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun 64 (1996) 1100-1109
210. Casteels K., Bouillon R., Waer M., and Mathieu C. Immunomodulatory effects of 1, 25-dihydroxy-vitamin D3. Curr Opin Nephrol Hypertens 4 (1995) 313-318
211. 3. J Neuroimmunol 61 (1995) 151-160
212. Lemire J. 1, 25-Dihydroxyvitamin D3-a hormone with immunomodulatory properties. Z Rheumatol 59 Suppl 1 (2000) 24-27
213. Shedpure M., and Pati A.K. The pineal gland: structural and functional diversity. Indian J Exp Biol 33 (1995) 625-640
214. Roberts J.E. Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology). J Photochem Photobiol B Biol 29 (1995) 3-15
215. Morrey K.M., McLachlan J.A., Serkin C.S., and Bakouche O. Activation of human monocytes by the pineal hormone melatonin. J Immunol 153 (1994) 2671-2680
216. DiStefano A., and Paulesu L. Inhibitory effect of melatonin on production of IFN gamma or TNF alpha in peripheral blood mononuclear cells of some blood donors. J Pineal Res 17 (1994) 164-169
217. Giordano M., Vermeulen M., and Palermo M.S. Seasonal variations in antibody-dependent cellular cytotoxicity regulation by melatonin. Int J Neurosci 68 (1993) 109-125
218. Mocchegiani E., Bulian D., Santarelli L., Tibaldi A., Mozzioli M., Pierpaoli W., and Fabris N. The immuno-reconstituting effect of melatonin or pineal grafting and its relation to zinc pool in aging mice. J Neuroimmunol 53 (1994) 189-201
219. Maestroni G.J. MLT and the immune-hematopoietic system. Adv. Exp Med. Biol 460 (1999) 395-405
220. Nelson R.J., and Drazen D.L. Melatonin mediates seasonal adjustments in immune function. Reprod Nutr Dev 39 3 (1999; May-Jun) 383-398
221. Levi-Montalcini R. The nerve growth factor, its mode of action on sensory and sympathetic nerve cells. Harvey Lectures 60 (1966) 217-259
222. Pezzati P., Stanisz A.M., Marshall J.S., Bienenstock J., and Stead R.H. Expression of nerve growth factor receptor immunoreactivity on follicular dendritic cells from human mucosa associated lymphoid tissues. Immunology 76 (1992) 485-490
223. Lomen-Hoerth C., and Shooter E.M. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J Neurochem 64 (1995) 1780-1789
224. Cosman D. A family of ligands for the TNF receptor superfamily. Stem Cells Dayt 12 (1994) 440-455
225. rsk in human B lymphocytes. J Immunol 154 (1995) 4965-4972
226. Manning P.T., Russell J.H., Simmons B., and Johnson E.M. Protection from guanethidine-induced neuronal destruction by nerve growth factor: effect of NGF on immune function. Brain Res 340 (1985) 61-69
227. Otten U., Ehrhard P., and Peck R. Nerve growth factor induces growth and differentiaton of human B lymphocytes. Proc Natl Acad Sci USA 86 (1989) 10059-10063
228. Kimata H., Yoshida A., Ishioka C., Kusunoki T., Hosoi S., and Mikawa H. Nerve growth factor specifically induces human IgG4 production. Eur J Immunol 21 (1991) 137-141
229. Brodie C., Oshiba A., Renz H., Bradley K., and Gelfand E.W. Nerve growth factor and anti-CD40 provide opposite signals for the production of IgE in inteleukin-4-treated lymphocytes. Eur J Immunol 26 (1996) 171-178
230. Santambrogio L., Benedetti M., Chao M.V., Muzaffar R., Kulig K., Gabellini N., and Hochwald G. Nerve growth factor production by lymphocytes. J Immunol 153 (1994) 4488-4495
231. Leon A., Buriani A., DalToso R., et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 91 (1994) 3739-3743
232. Aloe L., and Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 133 (1977) 358-366
233. Bohm A., Aloe L., and Levi-Montalcini R. Nerve growth factor enhances precocious differentiation and numerical increase in mast cells in cultures of rat splenocytes. Acad Naz Lineei 80 (1986) 1
234. Marshall J.S., Stead R.H., McSharry C., Nielsen L., and Bienenstock J. The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. J Immunol 144 (1990) 1886-1892
235. Bischoff S.C., and Dahinden C.A. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79 (1992) 2662-2669
236. Garaci E., Caroleo M.C., Aloe L., Aqaro S., Piacentini M., Costa N., Amendola A., Micera A., Calio R., Perno C.F., and Levi-Montalcini R. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Nat Acad Sci USA 96 (1999) 14013-14018
237. Gee A.P., Boyle M.D.P., Munger K.L., Lawman M.J., and Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci USA 80 (1983) 7215-7218
238. Boyle M.D.P., Lawman M.J.P., Gee A.P., and Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 135 (1985) 564-568
239. Banks B., Vernon C.A., and Warner J.A. Nerve growth factor has anti-inflammatory activity in the rat hind paw oedema test. Neurosci Lett 47 (1984) 41-45
240. Amico-Roxas M., Caruso A., Leone M.G., Scifo R., Vanella A., and Scapagnini U. Nerve growth factor inhibits some acute experimental inflammations. Arch Int Pharmacodyn Ther 299 (1989) 269-285
241. Braun A., Appel E., Baruch R., Herz U., Botchkarev V., Paus R., Brodie C., and Renz H. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 28 10 (1998; Oct) 3240-3251
242. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., and Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: aneuroprotective role of inflammation?. J Exp Med 189 5 (1999; Mar 1) 865-870
243. Besser M., and Wank R. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells andTh1/Th2-polarized expression of their receptors. Immunol 162 11 (1999; Jun 1) 6303-6306
244. Simone M.D., De Santis S., Vignetti E., Papa G., Amadori S., and Aloe L. Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol Oncol 1 (1999) 1-10
245. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., and Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 107 2 (2000; Jul 24) 161-166
246. Reinshagen M., Rohm H., Steinkamp M., Lieb K., Geerling I., Von Herbay A., Flamig G., Eysselein V.E., and Adler G. Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology 119 2 (2000; Aug) 368-376
247. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., and Schwartz M. Production of Neurotrophins by Activated T Cells: Implications for Neuroprotective Autoimmunity. J Autoimmun 15 3 (2000; Nov) 331-345
248. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., and Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 6696 (1998; Aug 27) 897-901
249. Bornstein S.R., Licinio J., Tauchnitz R., Engelmann L., Negrao A.B., Gold P., and Chrousos G.P. Plasma leptin levels are increased in survivors, of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 83 1 (1998; Jan) 280-283
250. Wauters M., Considine R.V., and Van Gaal L.F. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143 3 (2000; Sept) 293-311
251. Hosoi T., Okuma Y., and Nomura Y. Expression of leptin receptors and induction of IL-1beta transcript in glial cells. Biochem Biophys Res Commun 273 1 (2000; Jun 24) 312-315
252. Faggioni R., Moser A., Feingold K.R., and Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol 156 5 (2000; May) 1781-1787
253. Matarese G. Leptin and the immune system: how nutritional status influences the immune response. Eur Cytokine Netw 11 1 (2000; Mar) 7-14
254. Giovambattista A., Chisari A.N., Corro L., Gaillard R.C., and Spinedi E. Metabolic, neuroendocrine and immune functions in basal conditions and during the acute-phase response to endotoxic shock in undernourished rats. Neuroimmunomodulation 7 2 (2000) 92-98
255. Okamoto S., Irie Y., Ishikawa I., Kimura K., and Masayuki S. Central leptin suppresses splenic lymphocyte functions through activation of the corticotropin-releasing hormone-sympathetic nervous system. Brain Res 855 1 (2000; Feb 7) 192-197
256. Chautard T., Spinedi E., Voirol M., Pralong F.P., and Gaillard R.C. Role of glucocorticoids in the response of, the hypothalamo-corticotrope, immune and adipose, systems to repeated endotoxin administration. Neuroendocrinology 69 5 (1999; May) 360-369
257. Torpy D.J., Bornstein S.R., and Chrousos G.P. Leptin and interleukin-6 in sepsis. Horm Metab Res 30 12 (1998; Dec) 726-729
258. Pt 2. Faggioni R., Fantuzzi G., Gabay C., Moser A., Dinarello C.A., Feingold K.R., and Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276 1 (1999; Jan) R136-R142
259. Takahashi N., Waelput W., and Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp. Med 189 1 (1999; Jan 4) 207-212
260. Finck B.N., Kelley K.W., Dantzer R., and Johnson R.W. In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology 139 5 (1998; May) 2278-2283
261. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L., Wang D.J., Klein A.S., Bulkley G.B., Bao C., Noble P.W., Lane M.D., and Diehl A.M. Leptin regulates proinflammatory immune responses. FASEB J 12 1 (1998; Jan) 57-65
262. Fantuzzi G., and Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68 4 (2000; Oct) 437-446
263. Barach E.M., Nowak R.M., Lee T.G., and Tomlanovich M.C. Epinephrine for treatment of anaphylactic shock. JAMA 251 16 (1984) 2118-2122
264. Nelson H.S. Adrenergic therapy, of bronchial asthma. J Allergy Clin Immunol 77 6 (1986) 71-785
265. Livnat S., Felten S.Y., Carlson D.L., Bellinger F.L., and Felten D.L. Involvement of peripheral and central catecholamine systems in neural-immune interactions. J Neuroimmunol 10 (1985) 5-30
266. Cross R.J., Jackson J.C., Brooks W.H., Sparks D.L., Markesbery W.R., and Roszman T.L. Neuroimmunomodulation: Impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology 57 1 (1986) 145-152
267. Berczi I., and Nagy E. Neurohormonal control of cytokines during injury. In: Rothwell N.J., and Berkenbosch F. (Eds). Brain Control of Responses to Trauma (1994), Cambridge University Press 32-107
268. Schauenstein K., Rinner I., Felsner P., et al. The role of the adrenergic/cholinergic balance in the immune-neuroendocrine circuit. In: Berczi I., and Szelenyi J. (Eds). Advances in psychoneuroimmunology (1994), Plenum Press, New York 349-356
269. Nagatomi R., Kaifu T., Okutsu M., Zhang X., Kanemi O., and Ohmori H. Modulation of the immune system by the autonomic nervous system and its implication in, immunological changes after training. Exerc Immunol Rev 6 (2000) 54-74
270. Szelenyi J., Kiss J.P., and Vizi E.S. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J Neuroimmunol 103 1 (2000; Feb 1) 34-40
271. Bergmann M., Gornikiewicz A., Sautner T., Waldmann E., Weber T., Mittlbock M., Roth E., and Fugger R. Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock 12 6 (1999 Dec) 421-427
272. Schauenstein K., Rinner I., Felsner P., et al. The role of the adrenergic/ cholinergic balance in the immune-neuroendocrine circuit. In: Berczi I., and Szelenyi J. (Eds). Advances in psychoneuroimmunology (1994), Plenum Press, New York 349-356
273. Druce H.M., Wright R.H., Kossoff D., and Kaliner M.A. Cholinergic nasal hyperreactivity in atopic subjects. J Allergy Clin Immunol 76 (1985) 445-452
274. Coffey R.G., and Hadden J.W. Neurotransmitters, hormones, and cyclic nucleotides in lymphocyte regulation. Fed Proc 44 1 (1985) 112-117
275. Szelenyi J., and Ha N.T.H. Expression of cholinergic structure on lymphocytes. In: Berczi I., and Szelenyi J. (Eds). Advances in psychoneuroimmunology (1994), Plenum Press, New York 271-277
276. Payan D.G., McGillis J.P., Renold F.K., Mitsuhashi M., and Goetzl E.J. The immunomodulating properties of neuropeptides. In: Berczi I., and Kovacs K. (Eds). Hormones and immunity (1987), MTP Press, Lancaster, England
277. Foreman J.C. Neuropeptides and the pathogenesis of allergy. Allergy 42 1 (1987) 1-11
278. Shanahan F., Lee T.D.G., Bienenstock J., and Befus A.D. Mast cell heterogeneity: Effect of anti-allergic compounds on neuropeptide-induced histamine release. Int Arch Allergy Appl Immunol 80 4 (1986) 424-426
279. Jancso G., Obal Jr. F., Toth-Kasa I., Katona M., and Husz S. The modulation of cutaneous inflammatory reactions by peptide-containing sensory nerves. Int J Tissue React 7 6 (1985) 449-457
280. 2+ concentration and inositol phosphateformation. J Immunol 141 (1988) 2118-2124
281. Lotz M., Carson D.A., and Vaughan J.H. Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 235 4791 (1987) 893-895
282. Hartung H.P., Heininger K., Schafer B., and Toyka K.V. Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. Fed Am Soc Exp Biol J 2 (1988) 48-51
283. Damonneville M., Monte D., Auriault C., and Capron A. The neuropeptide substance-P stimulates, the effector functions of platelets. Clin Exp Immunol 81 (1990) 346-351
284. Rameshar P., Ganea D., and Gascon P. Induction of IL-3 and granulocyte-macrophage colonystimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J Immunol 152 (1994) 4044-4054
285. Mariott I., and Bost K.L. IL-4 and IFN-gamma up-regulate substance P receptor expression in murine peritoneal macrophages. J Immunol 165 1 (2000; Jul 1) 182-191
286. Blum A.M., Metwali A., Kim-Miller M., Li J., Qadir K., Elliott D.E., Lu B., Fabry Z., Gerard N., and Weinstock J.V. The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni. J Immunol 162 10 (1999; May 15) 6080-6085
287. (this volume). Bienenstock J. A model of neuroimmune communication: Mast cells and nerves. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New foundation of Biology (2001), Elsevier, Amsterdam 195-202
288. Mullins M.W., Ciallella J., Rangnekar V., and McGillis J.P. Characterization of a calcitonin gene-related peptide (CGRP) receptor on mouse bone marrow cells. Regul Pept 49 (1993) 65-72
289. Nong Y.H., Titus R.G., Ribeiro J.M.C., and Remold H.G. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 145 (1989) 45-49
290. Wang X., Fiscus R.R., Tang Z., et al. CGRP in the serum of endotoxin-treated rats suppresses lymphoproliferation. Brain Behav Immun 8 (1994) 282-292
291. Hosoi J., Murphy G.F., Egan C.L., et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363 (1993) 159-163
292. Asahina A., Hosoi J., Beissert S., Stratigos A., and Granstein R.D. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 154 (1995) 3056-3061
293. Millet I., Phillips R.J., Sherwin R.S., Ghosh S., Voll R.E., Flavell R.A., Vignery A., and Rincon M. Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J Biol Chem 275 20 (2000; May 19) 15114-15121
294. Wang X., Xing L., Xing Y., Tang Y., and Han C. Identification and characterization of immunoreactive calcitonin gene-related peptide from lymphocytes of the rat. J Neuroimmunol 94 1-2 (1999; Feb 1) 95-102
295. Streilein J.W., Alard P., and Niizeki H. A new concept of skin-associated lymphoid tissue (SALT): UVB light impaired cutaneous immunity reveals a prominent role for cutaneous nerves. Keio J Med 48 1 (1999; Mar) 22-27
296. Foris G., Gyimesi E., and Komaromi I. The mechanism of antibody-dependent cellular cytotoxicity stimulation by somatostatin in rat peritoneal macrophages. Cell Immunol 90 1 (1985) 217-225
297. Muscettola M., and Grasso G. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology 180 (1990) 419-430
298. Church M.K., El-Lati S., and Caulfield J.P. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 94 (1991) 310-318
299. Bokum A.M., Hofland L.J., and van Hagen P.M. Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw 11 2 (2000; Jun) 161-176
300. Szolcsanyi J., Helyes Z., Oroszi G., Nemeth J., and Pinter E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 123 5 (1998; Mar) 936-942
301. Ottaway C.A. In vitro alterations of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J Exp Med 160 4 (1984) 1054-1069
302. O'Dorisio M.S. Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous endocrine and immune systems. Fed Proc 46 1 (1987) 192-195
303. Kimata H., and Fujimoto M. Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production. Eur J Immunol 24 (1994) 2262-2265
304. Xin Z., Tang H., and Ganea D. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J Neuroimmunol 54 (1994) 59-68
305. Boirivant M., Fais S., Annibale B., Agostini D., Delle Fave G., and Pallone F. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 106 (1994) 576-582
306. Delgado M., and Ganea D. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylatecyclase-activating polypeptide. J Immunol 165 6 (2000; Sep 15) 3051-3057
307. Sun W., Tadmori I., Yang L., Delgado M., and Ganea D. Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages. J Neuroimmunol 107 1 (2000; Jul 10) 88-99
308. Xin Z., and Sriram S. Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages. J Neuroimmunol 89 1-2 (1998; Aug 14) 206-212
309. Kawamura N., Tamura H., Obana S., Wenner M., Ishikawa T., Nakata A., and Yamamoto H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5 1-2 (1998; Jan-Apr) 9-15
310. Martinez C., Delgado M., Pozo D., Leceta J., Calvo J.R., Ganea D., and Gomariz R.P. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J Leukoc Biol 63 5 (1998; May) 591-601
311. Tang H., Sun L., Xin Z., and Ganea D. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP. Ann N Y Acad Sci 805 (1996; Dec 26) 768-778
312. Martinez C., Delgado M., Pozo D., Leceta J., Calvo J.R., Ganea D., and Gomariz R.P. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies. J Neuroimmunol 85 2 (1998; May 15) 155-167
313. Delgado M., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes byinhibiting Fas ligand expression. J Immunol 164 3 (2000; Feb 1) 1200-1210
314. Taylor A.W., Streilein J.W., and Cousins S.W. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous homor. J Immunol 153 (1994) 1080-1086
315. Ferguson T.A., Fletcher S., Herndon J., and Griffith T.S. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol 155 (1995) 1746-1756
316. Lundeberg L., Mutt V., and Nordlind K. Inhibitory effect of vasoactive intestinal peptide on the challenge phase of allergic contact dermatitis in humans. Acta Derm Venereol 79 3 (1999; May) 178-182
317. In: Frontiers F.B., Hames B.D., and Glover D.M. (Eds). The Cytokine Network (2000), Oxford in Molecular Biology Series University Press series editors
318. Grignani G. Maiolo, Cytokines and hemostasis. A Haematologica 85 9 (2000; Sept) 967-972
319. th edition (1999), Lippincott-Raven 741-774
320. th edition (1999), Lippincott-Raven 775-811
321. Mathison R.T., Davison J.S., and Befus A.D. Neuroendocrine regulation of inflammation and tissue repair by submandibular gland factors. Immunology Today 14 (1994) 527-532
322. Berczi I., Chow D.A., and Sabbadini E.R. Neuroimmunoregulation and natural immunity. Domestic Anim Endocrin 15 (1998) 273-281
323. Sabbadini E.R., and Berczi I. Immunoregulation by the salivary glands. Biomed Rev 9 (1998) 79-91
324. Befus D et al. Immunomodulation by the submandibular gland. Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Amsterdam, Elsevier (this volume): 203-224.
325. Sabbadini et al. Immunoregulation by glandular kallikrein.Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Amsterdam, Elsevier (this volume): 225-235.
326. Brandtzaeg P., Farstad I.N., Haraldsen G., and Jahnsen F.L. Cellular and molecular mechanisms for induction of mucosal immunity. Dev Biol Stand 92 (1998) 93-108
327. Chen Y.H., and Weiner H.L. Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann N Y Acad Sci 778 (1996; Feb 13) 111-121
328. Davison J. The Salivary Gland Peptides: Their Role in Anaphylaxis and Lipopolysaccharide (LPS)-Induced Inflammation. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Ireland 307-311
329. McDermott M.R., Clark D.A., and Bienenstock J. Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol 124 6 (1980; Jun) 2536-2539
330. Nagy E., and Berczi I. Pituitary dependence of bone marrow function. Brit J Haematol 71 (1989) 457-462
331. Berczi I., and Nagy E. Effects of hypophysectomy on immune function. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology II (1991), Academic Press 339-375
332. Bernard C. Lecons sur les phenomenes de la vie communs aux animaux et aux vegetaux (1878), Balliere, Paris
333. Berczi I. Neurohormonal host defence in endotoxin shock. Ann NY Acad Sci 840 (1998) 787-802
334. Berczi I, Bertok L, Chow D. Natural immunity and neuroimmune host defence. AnnNY Acad Sci (in press).
335. Medzhitov R., and Janeway Jr. C. Innate immune recognition: mechanisms and pathways. Immunol Rev 173 (2000; Feb) 89-97
336. Berczi I. The stress concept and neuroimmunoregulation in modern biology. Ann NY Acad Sci 851 (1998) 3-12
337. Berczi I. Neuroendocrine defence in endotoxin shock. (A review). Acta Microbiol Hun 40 4 (1993) 265-302
338. Berczi I., and Nagy E. Neurohormonal control of cytokines during injury. In: Rothwell N.J., and Berkenbosch F. (Eds). Brain Control of Responses to Trauma (1994), Cambridge University Press 32-107
339. Berczi I. Neuroendocrine response to endotoxin. Ann NY Acad Sci 851 (1998) 411-415
340. Haeryfar SMM, Berczi I. The thymus and the acute phase response. Mol Cell Biol(in press).
341. Pittman Q.J., Chen X., Mouihate A., and Martin S. Vasopressin-induced atipyresis. Sex- and experience-dependent febrile response. Ann NY Acad Sci 856 (1998) 53-61
342. McEwen B.S. Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity. Neurochem Res 25 9-10 (2000; Oct) 1219-1231
343. Anisman H., Baines M.G., Berczi I., Bernstein C.N., Blennerhassett M.G., Gorczynski R.M., Greenberg A.H., Kisil F.T., Mathison R.D., Nagy E., Nance D.M., Perdue M.H., Pomerantz D.K., Sabbadini E.R., Stanisz A., and Warrington R.J. Neuroimmune mechanisms in health and disease: 1. Health. Can Med Assoc J 155 7 (1996) 867-874
344. Gorczinsky R. Understanding classical conditioning of immune responses. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Amsterdam 237-254
345. Pomerantz D. Interactions Between the Immune and the Reproductive Systems. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Amsterdam 237-254
346. Luheshi G. Leptin and Cytokines: Actions and Interactions in Fever and Appetite Control. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Amsterdam 283-292
347. Baines M. Olfactory Stimuli and Allo-Recognition. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune Biology: New Foundation of Biology (2001), Elsevier, Amsterdam 313-329
348. Berczi I., Nagy E., Asa S.L., and Kovacs K. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum 27 (1984) 682-688
349. Nagy E., Friesen H.G., Sehon A.H., and Berczi I. Immunomodulation in rats by transplantable anterior pituitary tumors. Endocrinology 116 (1985) 1117-1122
350. Nagy E., and Berczi I. Immunomodulation by tamoxifen and pergolide. Immunopharmacology 12 (1986) 145-153
351. I. Berczi I., Cosby H., Hunter T., Baragar F., McNeilly A.S., and Friesen H.G. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Brit J Rheum 26 (1987) 433-436
352. Nagy E., Chalmers I.M., Baragar F.D., Friesen H.G., and Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 18 (1991) 1662-1668
353. Ramachandra R.N., Sehon A.H., and Berczi I. Neuro-hormonal host defence in endotoxin shock. Brain Behav Immun 6 (1992) 157-169
354. Baral E., Nagy E., and Berczi I. Target cells are sensitized for cytotoxic T lymphocyte mediated destruction by estradiol and tamoxifen. Int J Cancer 58 (1994) 64-68
355. Baral E., Nagy E., and Berczi I. Modulation of natural killer cell mediated cytotoxicity by tamoxifen and estradiol. Cancer 75 (1995) 591-599
356. Anisman H., Baines M.G., Berczi, Bernstein C.N., Blennerhassett M.G., Gorczynski R.M., Greenberg A.H., Kisil F.T., Mathison R.D., Nagy E., Nance D.M., Perdue M.H., Pomerantz D.K., Sabbadini E.R., Stanisz A., and Warrington R.J. Neuroimmune mechanisms in health and disease: 2. Disease. Can Med Assoc J 155 8 (1996) 1075-1082
357. In: McCann S.M., Lipton J.M., Sternberg E.M., Chrousos G.P., Gold P.W., and Smith C.C. (Eds). Neuroimmunomodulation: Molecular aspects, integrative systems, and clinical advances. Ann NY Acad Sci (1998) 840
358. In: Csermely P. (Ed). Stress of life, from molecules to man. Ann NY Acad Sci 851 (1998)
359. (in press). Dickstein J., and Moldofsky H. Sleep, cytokines and immune function. Sleep Medicine Reviews 3 3 (1999)
360. Rivest S., Lacroix S., Vallieres L., Nadeau S., Zhang J., and Laflamme N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med 223 (2000) 22-38